Furthermore, GFAP has been found to possess diagnostic significance in predicting the progression of MCI to AD (Cicognola et al., 2021; Abdelhak et al., 2022; Heimfarth et al., 2022). The gene discussed is GFAP; the disease is Alzheimer disease.